[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
August 17, 2005

Office-Based Treatment for Opioid Addiction Achieving Goals

JAMA. 2005;294(7):784-786. doi:10.1001/jama.294.7.784

Orlando, Fla—Many individuals with opioid addictions who might otherwise go untreated are seeking office-based buprenorphine treatment and many are having positive outcomes, according to emerging data on the 3-year-old treatment program. But challenges remain for patients seeking care and the physicians who treat them.

Office-based buprenorphine treatment represents a new paradigm for treating opioid addiction. While methadone treatment through clinics has proven effective for many with opioid addictions, the stigma associated with the clinics, constraints on their locations, and the logistics of getting to them for daily treatment have been obstacles for some individuals, explained Arlene Stanton, PhD, social science analyst at the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration (SAMHSA) in Washington, DC. Officials hoped that making buprenorphine available through qualified primary care physicians and addiction specialists would attract a new group of patients to treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview